Peptide Receptor Radionuclide Therapy (PRRT) of Neuroendocrine Tumor Patients with Carcinoid Heart Disease

被引：0
|
作者：
Prasad, V [1 ]
Secknus, M. A. [1 ]
Hoersch, D. [1 ]
Kuntze, T. [1 ]
Zachert, C. [1 ]
Baum, R. P. [1 ]
机构：
[1] Zent Klin Bad Berka, Bad Berka, Germany
来源：
NEUROENDOCRINOLOGY | 2009年 / 90卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation
    Savelli, Giordano
    Zaniboni, Alberto
    Bertagna, Francesco
    Bosio, Giovanni
    Nisa, Lutfun
    Rodella, Carlo
    Biasiotto, Giorgio
    Bettinsoli, Giovanni
    Migliorati, Elena
    Peli, Alessia
    Falchi, Roberta
    Giuffrida, Francesca
    Giubbini, Raffaele
    BREAST CARE, 2012, 7 (05) : 408 - 410
  • [42] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs): A United States Experience
    Katona, Bryson
    Riff, Brian
    Soulen, Michael
    Pryma, Daniel
    Bennett, Bonita
    Wild, Damian
    Nicolas, Guillaume
    Teitelbaum, Ursina
    Metz, David
    PANCREAS, 2017, 46 (03) : 439 - 439
  • [43] Can tumor absorbed dose predict response to Peptide Receptor Radionuclide Therapy (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)?
    Mileva, M.
    Marin, G.
    Levillain, H.
    van Bogaert, C.
    Critchi, G.
    Marin, C.
    Flamen, P.
    Karfis, I
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 153 - 153
  • [44] Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients
    Theiler, Deborah
    Cattaneo, Marco
    Dierickx, Lawrence O.
    Igaz, Peter
    Grozinsky-Glasberg, Simona
    Bournaud, Claire
    O'Dorisio, Thomas
    O'Dorisio, M. Sue
    Wild, Damian
    Christ, Emanuel
    Nicolas, Guillaume P.
    CANCERS, 2021, 13 (24)
  • [45] Positron Emission Tomography (PET) Predictors of Tumor Response to Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic Neuroendocrine Tumors (NET)
    Ladwa, R.
    Pattison, D.
    Smith, J.
    Goodman, S.
    Burge, M.
    Rose, S.
    Dowson, N.
    Wyld, D.
    NEUROENDOCRINOLOGY, 2018, 106 : 249 - 249
  • [46] Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status
    Moncayo, Roy
    Traeger, Annette
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (08) : 1580 - 1581
  • [47] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS: THE UNIVERSITY GENERAL HOSPITAL OF ATHENS "ATTIKON" PARADIGM
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6031 - 6031
  • [48] Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status
    Roy Moncayo
    Annette Traeger
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1580 - 1581
  • [49] Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor
    Daniel Kaemmerer
    Vikas Prasad
    Wolfgang Daffner
    Dieter Hrsch
    Günter Klppel
    Merten Hommann
    Richard P Baum
    World Journal of Gastroenterology, 2009, 15 (46) : 5867 - 5870
  • [50] Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor
    Kaemmerer, Daniel
    Prasad, Vikas
    Daffner, Wolfgang
    Hoersch, Dieter
    Kloeppel, Guenter
    Hommann, Merten
    Baum, Richard P.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (46) : 5867 - 5870
12345